Skip to main content
Premium Trial:

Request an Annual Quote

Organon Extends and Expands GeneGo's License

NEW YORK (GenomeWeb News) - Organon has extended and expanded its license of GeneGo's software and database products, GeneGo said today.
 
Organon has extended its license of the MetaCore data analysis platform from a deal it originally signed with GeneGo in 2005.
 
Under the new agreement, the Dutch pharmaceuticals developer also added a new license for GeneGo's MetaLink software.
 
Financial terms of the agreements were not released.

The Scan

For Better Odds

Bloomberg reports that a child has been born following polygenic risk score screening as an embryo.

Booster Decision Expected

The New York Times reports the US Food and Drug Administration is expected to authorize a booster dose of the Pfizer-BioNTech SARS-CoV-2 vaccine this week for individuals over 65 or at high risk.

Snipping HIV Out

The Philadelphia Inquirer reports Temple University researchers are to test a gene-editing approach for treating HIV.

PLOS Papers on Cancer Risk Scores, Typhoid Fever in Colombia, Streptococcus Protection

In PLOS this week: application of cancer polygenic risk scores across ancestries, genetic diversity of typhoid fever-causing Salmonella, and more.